Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.2 USD
1.59 B USD
14.24 B USD
1.47 B
About Boston Scientific Corporation
Sector
Industry
CEO
Michael F. Mahoney
Website
Headquarters
Marlborough
Founded
1979
FIGI
BBG00JRY9V97
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049Yield to maturity
5.57%
Maturity date
Mar 1, 2049
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039Yield to maturity
5.41%
Maturity date
Mar 1, 2039
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040Yield to maturity
5.26%
Maturity date
Jan 15, 2040
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030Yield to maturity
5.08%
Maturity date
Jun 1, 2030
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029Yield to maturity
4.88%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028Yield to maturity
4.86%
Maturity date
Mar 1, 2028
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026Yield to maturity
4.78%
Maturity date
Mar 1, 2026
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025Yield to maturity
4.71%
Maturity date
Jun 1, 2025
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEEDYield to maturity
3.45%
Maturity date
Mar 8, 2034
Explore more bonds
Frequently Asked Questions
The current price of 0HOY is 90.3 USD — it has decreased by −1.37% in the past 24 hours. Watch BOSTON SCIENTIFIC CORP COM USD0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BOSTON SCIENTIFIC CORP COM USD0.01 stocks are traded under the ticker 0HOY.
0HOY stock has risen by 3.58% compared to the previous week, the month change is a 5.02% rise, over the last year BOSTON SCIENTIFIC CORP COM USD0.01 has showed a 62.20% increase.
We've gathered analysts' opinions on BOSTON SCIENTIFIC CORP COM USD0.01 future price: according to them, 0HOY price has a max estimate of 110.00 USD and a min estimate of 86.00 USD. Watch 0HOY chart and read a more detailed BOSTON SCIENTIFIC CORP COM USD0.01 stock forecast: see what analysts think of BOSTON SCIENTIFIC CORP COM USD0.01 and suggest that you do with its stocks.
0HOY reached its all-time high on Nov 22, 2024 with the price of 91.8 USD, and its all-time low was 22.2 USD and was reached on Jan 18, 2018. View more price dynamics on 0HOY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0HOY stock is 2.96% volatile and has beta coefficient of 0.76. Track BOSTON SCIENTIFIC CORP COM USD0.01 stock price on the chart and check out the list of the most volatile stocks — is BOSTON SCIENTIFIC CORP COM USD0.01 there?
Today BOSTON SCIENTIFIC CORP COM USD0.01 has the market capitalization of 132.65 B, it has increased by 5.18% over the last week.
Yes, you can track BOSTON SCIENTIFIC CORP COM USD0.01 financials in yearly and quarterly reports right on TradingView.
BOSTON SCIENTIFIC CORP COM USD0.01 is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
0HOY earnings for the last quarter are 0.63 USD per share, whereas the estimation was 0.59 USD resulting in a 7.08% surprise. The estimated earnings for the next quarter are 0.65 USD per share. See more details about BOSTON SCIENTIFIC CORP COM USD0.01 earnings.
BOSTON SCIENTIFIC CORP COM USD0.01 revenue for the last quarter amounts to 4.21 B USD, despite the estimated figure of 4.04 B USD. In the next quarter, revenue is expected to reach 4.40 B USD.
0HOY net income for the last quarter is 469.00 M USD, while the quarter before that showed 324.00 M USD of net income which accounts for 44.75% change. Track more BOSTON SCIENTIFIC CORP COM USD0.01 financial stats to get the full picture.
No, 0HOY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 48.00 K employees. See our rating of the largest employees — is BOSTON SCIENTIFIC CORP COM USD0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOSTON SCIENTIFIC CORP COM USD0.01 EBITDA is 3.86 B USD, and current EBITDA margin is 23.71%. See more stats in BOSTON SCIENTIFIC CORP COM USD0.01 financial statements.
Like other stocks, 0HOY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOSTON SCIENTIFIC CORP COM USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOSTON SCIENTIFIC CORP COM USD0.01 technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOSTON SCIENTIFIC CORP COM USD0.01 stock shows the strong buy signal. See more of BOSTON SCIENTIFIC CORP COM USD0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.